{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:04:48Z","timestamp":1770228288590,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Emerg Radiol"],"DOI":"10.1007\/s10140-024-02286-2","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T11:02:35Z","timestamp":1727434955000},"page":"937-941","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Amyloid related imaging abnormalities in the emergency setting"],"prefix":"10.1007","volume":"31","author":[{"given":"Jan","family":"Czerminski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supriya","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9945-1300","authenticated-orcid":false,"given":"Balaji","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"2286_CR1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.14283\/jpad.2021.41","volume":"8","author":"J Cummings","year":"2021","unstructured":"Cummings J, Aisen P, Apostolova LG et al (2021) Aducanumab: Appropriate Use Recommendations. J Prev Alzheimers Dis 8:398\u2013410. https:\/\/doi.org\/10.14283\/jpad.2021.41","journal-title":"J Prev Alzheimers Dis"},{"key":"2286_CR2","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R (2020) Comprehensive Review on Alzheimer\u2019s Disease: Causes and Treatment. Molecules 25:5789. https:\/\/doi.org\/10.3390\/molecules25245789","journal-title":"Molecules"},{"key":"2286_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack","year":"2010","unstructured":"Jack CR, Knopman DS, Jagust WJ et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol 9:119\u2013128. https:\/\/doi.org\/10.1016\/S1474-4422(09)70299-6","journal-title":"Lancet Neurol"},{"key":"2286_CR4","doi-asserted-by":"publisher","first-page":"e230009","DOI":"10.1148\/rg.230009","volume":"43","author":"A Agarwal","year":"2023","unstructured":"Agarwal A, Gupta V, Brahmbhatt P et al (2023) Amyloid-related imaging abnormalities in alzheimer disease treated with anti-amyloid-\u03b2 therapy. Radiographics 43:e230009. https:\/\/doi.org\/10.1148\/rg.230009","journal-title":"Radiographics"},{"key":"2286_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Jack CR, Black SE et al (2011) Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup. Alzheimers Dement 7:367\u2013385. https:\/\/doi.org\/10.1016\/j.jalz.2011.05.2351","journal-title":"Alzheimers Dement"},{"key":"2286_CR6","unstructured":"(2024) Biogen to Realign Resources for Alzheimer\u2019s Disease. https:\/\/investors.biogen.com\/news-releases\/news-release-details\/biogen-realign-resources-alzheimers-disease-franchise. Accessed 18 Sep 2024"},{"key":"2286_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","volume":"79","author":"S Salloway","year":"2022","unstructured":"Salloway S, Chalkias S, Barkhof F et al (2022) Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early alzheimer disease. JAMA Neurol 79:13\u201321. https:\/\/doi.org\/10.1001\/jamaneurol.2021.4161","journal-title":"JAMA Neurol"},{"key":"2286_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P et al (2023) Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med 388:9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"key":"2286_CR9","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan Evans C et al (2021) Donanemab in Early Alzheimer\u2019s Disease. N Engl J Med 384:1691\u20131704. https:\/\/doi.org\/10.1056\/NEJMoa2100708","journal-title":"N Engl J Med"},{"key":"2286_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T et al (2016) The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537:50\u201356. https:\/\/doi.org\/10.1038\/nature19323","journal-title":"Nature"},{"key":"2286_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/jamaneurol.2021.5205","volume":"79","author":"M Filippi","year":"2022","unstructured":"Filippi M, Cecchetti G, Spinelli EG et al (2022) Amyloid-Related Imaging Abnormalities and \u03b2-Amyloid-Targeting Antibodies: A Systematic Review. JAMA Neurol 79:291\u2013304. https:\/\/doi.org\/10.1001\/jamaneurol.2021.5205","journal-title":"JAMA Neurol"},{"key":"2286_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","volume":"11","author":"R Sperling","year":"2012","unstructured":"Sperling R, Salloway S, Brooks DJ et al (2012) Amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol 11:241\u2013249. https:\/\/doi.org\/10.1016\/S1474-4422(12)70015-7","journal-title":"Lancet Neurol"},{"key":"2286_CR13","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3233\/JAD-180675","volume":"66","author":"HR Brashear","year":"2018","unstructured":"Brashear HR, Ketter N, Bogert J et al (2018) Clinical evaluation of amyloid-related imaging abnormalities in Bapineuzumab Phase III Studies. J Alzheimers Dis 66:1409\u20131424. https:\/\/doi.org\/10.3233\/JAD-180675","journal-title":"J Alzheimers Dis"},{"key":"2286_CR14","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3174\/ajnr.A3500","volume":"34","author":"J Barakos","year":"2013","unstructured":"Barakos J, Sperling R, Salloway S et al (2013) MR imaging features of amyloid-related imaging abnormalities. AJNR Am J Neuroradiol 34:1958\u20131965. https:\/\/doi.org\/10.3174\/ajnr.A3500","journal-title":"AJNR Am J Neuroradiol"},{"key":"2286_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11910-015-0572-y","volume":"15","author":"HS Kirshner","year":"2015","unstructured":"Kirshner HS, Bradshaw M (2015) The inflammatory form of cerebral amyloid angiopathy or \u201cCerebral Amyloid Angiopathy-Related Inflammation\u201d (CAARI). Curr Neurol Neurosci Rep 15:54. https:\/\/doi.org\/10.1007\/s11910-015-0572-y","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2286_CR16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3174\/ajnr.A3475","volume":"34","author":"F Barkhof","year":"2013","unstructured":"Barkhof F, Daams M, Scheltens P et al (2013) An MRI rating scale for amyloid-related imaging abnormalities with edema or effusion. AJNR Am J Neuroradiol 34:1550\u20131555. https:\/\/doi.org\/10.3174\/ajnr.A3475","journal-title":"AJNR Am J Neuroradiol"},{"key":"2286_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12503","volume":"15","author":"L Bracoud","year":"2023","unstructured":"Bracoud L, Klein G, Lyons M et al (2023) Validation of 3- and 5-point severity scales to assess ARIA-E. Alzheimers Dement (Amst) 15:e12503. https:\/\/doi.org\/10.1002\/dad2.12503","journal-title":"Alzheimers Dement (Amst)"},{"key":"2286_CR18","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2214\/AJR.22.28461","volume":"220","author":"M Roytman","year":"2023","unstructured":"Roytman M, Mashriqi F, Al-Tawil K et al (2023) Amyloid-related imaging abnormalities: an update. AJR Am J Roentgenol 220:562\u2013574. https:\/\/doi.org\/10.2214\/AJR.22.28461","journal-title":"AJR Am J Roentgenol"},{"key":"2286_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1148\/radiol.2015150473","volume":"278","author":"PV Pandharipande","year":"2016","unstructured":"Pandharipande PV, Reisner AT, Binder WD et al (2016) CT in the emergency department: a real-time study of changes in physician decision making. Radiology 278:812\u2013821. https:\/\/doi.org\/10.1148\/radiol.2015150473","journal-title":"Radiology"}],"container-title":["Emergency Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10140-024-02286-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10140-024-02286-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10140-024-02286-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T18:04:34Z","timestamp":1733594674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10140-024-02286-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":19,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2286"],"URL":"https:\/\/doi.org\/10.1007\/s10140-024-02286-2","relation":{},"ISSN":["1438-1435"],"issn-type":[{"value":"1438-1435","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"18 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}